SMTL ID : 9axs.1

Crystal Structure of HY18-5B1_Ch Fab in the Apo Conformation

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.04 Å

Oligo State

hetero-1-1-mer

Ligands

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 3 residues within 4Å: Chain A: N.161, Q.198, T.199 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.161, A:T.199 GOL.2: 11 residues within 4Å: Chain A: F.172, P.173, V.175, S.183, L.184, S.185 Chain B: Q.160, S.162, S.176, S.177, T.178 6 PLIP interactions: 4 interactions with chain B, 2 interactions with chain A Hydrogen bonds: B:Q.160, B:S.162, B:T.178, B:T.178, A:F.172, A:S.185

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rodarte, J. et al., Structure-Based Engineering of Monoclonal Antibodies for Improved Binding to Counteract the Effects of Fentanyl and Carfentanil. Acs Omega (2024)

Release Date

2024-10-02

Peptides

HY18-5B1_Ch Fab Heavy Chain: A
HY18-5B1_Ch Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

HY18-5B1_Ch Fab Heavy Chain

HY18-5B1_Ch Fab Light Chain

Related Entries With Identical Sequence